{"content":"<li class=\"n-box-item date-title\" data-end=\"1528516799\" data-start=\"1528430400\" data-txt=\"Monday, December 23, 2019\">Friday, June  8, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3362839\" data-ts=\"1528493734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRON\" target=\"_blank\">CRON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362839-after-hours-gainers-losers-06-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (06/08/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>&nbsp;<font color='green'>+2.3%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='green'>+1.9%</font>. <a href='https://seekingalpha.com/symbol/TISI' title='Team, Inc.'>TISI</a>&nbsp;<font color='green'>+1.7%</font>. <a href='https://seekingalpha.com/symbol/NCSM' title='NCS Multistage Holdings'>NCSM</a> <font color='green'>+1.5%</font>. <a href='https://seekingalpha.com/symbol/BCOV' title='Brightcove'>BCOV</a>&nbsp;<font color='green'>+1.5%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a> <font color='red'>-7.7%</font>. <a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics'>ACRS</a>&nbsp;<font color='red'>-3.2%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/LTM' title='LATAM Airlines Group S.A.'>LTM</a>&nbsp;<font color='red'>-3.2%.&nbsp;</font><a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a>&nbsp;<font color='red'>-3.0%</font>. <a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>&nbsp;<font color='red'>-2.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3362839\" data-linked=\"After Hours Gainers / Losers (06/08/2018)\" data-tweet=\"$CRON $CRON $LGCY - After Hours Gainers / Losers (06/08/2018) https://seekingalpha.com/news/3362839-after-hours-gainers-losers-06-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3362839-after-hours-gainers-losers-06-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362838\" data-ts=\"1528493665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WEB\" target=\"_blank\">WEB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362838-web-complus-5-starboard-value-discloses-9_4-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Web.com +5% as Starboard Value discloses 9.4% stake</a></h4><ul>   <li>Web.com Group (NASDAQ:<a href='https://seekingalpha.com/symbol/WEB' title='Web.com Group, Inc'>WEB</a>) is <font color='green'>up 5%</font> postmarket with a <a href=\"https://seekingalpha.com/filing/4061825\" target=\"_blank\">13D filing</a> showing a 9.4% stake taken by Starboard Value.</li>    <li>The investment manager through affiliated funds is beneficial owner of 4,630,579 shares, according to the filing.</li>    <li>Purchases took place throughout May and June to date.</li>    <li>Since May 2, when the filing notes purchasing began, shares of Web.com are <font color='green'>up 8.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362838\" data-linked=\"Web.com +5% as Starboard Value discloses 9.4% stake\" data-tweet=\"$WEB - Web.com +5% as Starboard Value discloses 9.4% stake https://seekingalpha.com/news/3362838-web-complus-5-starboard-value-discloses-9_4-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3362838-web-complus-5-starboard-value-discloses-9_4-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362823\" data-ts=\"1528489973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBIO\" target=\"_blank\">IBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362823-ibio-completes-1-10-reverse-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBio completes 1:10 reverse split</a></h4><ul><li>Nano cap iBio (NYSEMKT:<a href='https://seekingalpha.com/symbol/IBIO' title='iBio, Inc.'>IBIO</a>) has <a href=\"https://seekingalpha.com/pr/17187546-ibio-inc-announces-completion-1minus-10-reverse-stock-split\" target=\"_blank\">completed </a>its previously announced 1:10 reverse split of its common stock. Post-split trading will commence in Monday, June 11.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362823\" data-linked=\"IBio completes 1:10 reverse split\" data-tweet=\"$IBIO - IBio completes 1:10 reverse split https://seekingalpha.com/news/3362823-ibio-completes-1-10-reverse-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3362823-ibio-completes-1-10-reverse-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362818\" data-ts=\"1528489153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNA\" target=\"_blank\">SYNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362818-synaptics-closes-dayplus-10_8-previously-declined-dialogs-59-share-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synaptics closes day +10.8%, previously declined Dialog&#39;s $59/share bid</a></h4><ul><li>        Synaptics (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNA' title='Synaptics Incorporated'>SYNA</a>) closed today&rsquo;s wild ride&nbsp;<font color='green'>up 10.8%</font>&nbsp;on reports the company is in deal talks with Dialog Semiconductor (<a href='https://seekingalpha.com/symbol/DLGNF' title='Dialog Semiconductor Plc'>OTCPK:DLGNF</a>).</li><li>               A <a href=\"https://www.cnbc.com/2018/06/08/dialog-semiconductor-in-advanced-talks-to-acquire-synaptics.html\" target=\"_blank\">CNBC source</a> says Synaptics rejected Dialog&rsquo;s initial offer of $59/share in cash, which was offered in March.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362779-update-synaptics-plus-2-percent-potential-dialog-semi-deal\" target=\"_blank\">Update: Synaptics +2% on potential Dialog Semi deal</a> (June 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362818\" data-linked=\"Synaptics closes day +10.8%, previously declined Dialog&#39;s $59/share bid\" data-tweet=\"$SYNA $SYNA $DLGNF - Synaptics closes day +10.8%, previously declined Dialog&#39;s $59/share bid https://seekingalpha.com/news/3362818-synaptics-closes-dayplus-10_8-previously-declined-dialogs-59-share-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3362818-synaptics-closes-dayplus-10_8-previously-declined-dialogs-59-share-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362816\" data-ts=\"1528489121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEMD\" target=\"_blank\">AEMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362816-aethlon-medical-beats-0_02\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aethlon Medical beats by $0.02</a></h4><ul><li>Aethlon Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a>): FY EPS of -$0.46 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $0.15M (-61.5% Y/Y)</li><li>Shares <font color='green'>+2.31%</font>.</li><li><a href='https://seekingalpha.com/pr/17187530-aethlon-medical-announces-fiscal-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3362816\" data-linked=\"Aethlon Medical beats by $0.02\" data-tweet=\"$AEMD - Aethlon Medical beats by $0.02 https://seekingalpha.com/news/3362816-aethlon-medical-beats-0_02?source=tweet\" data-url=\"https://seekingalpha.com/news/3362816-aethlon-medical-beats-0_02\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362811\" data-ts=\"1528488399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGRX\" target=\"_blank\">EGRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362811-court-awards-orphan-drug-exclusivity-for-eagle-pharmas-bendeka-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Court awards Orphan Drug exclusivity for Eagle Pharma&#39;s Bendeka; shares up 6%</a></h4><ul><li>Thinly traded Eagle Pharmaceuticals (<a href='https://seekingalpha.com/symbol/EGRX' title='Eagle Pharmaceuticals Inc.'>EGRX</a> <font color='green'>+6.1%</font>) finished the session in the green on more than double normal on the news that a judge ruled in its favor regarding seven years of U.S. market exclusivity for blood cancer drug Bendeka (bendamustine hydrochloride).</li><li>The company sued the FDA in 2016 after it rejected Orphan Drug-related exclusivity citing the lack of evidence of clinical superiority.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3169656-fda-rejects-eagle-pharmas-market-exclusivity-request-blood-cancer-drug-bendeka\" target=\"_blank\">FDA rejects Eagle Pharma's market exclusivity request for blood cancer drug BENDEKA</a> (March 28, 2016)</li><li><strong>Update</strong>: In a <a href=\"https://seekingalpha.com/pr/17187833-court-issues-decision-favor-eagle-pharmaceuticals-granting-seven-year-orphan-drug-exclusivity\" target=\"_blank\">statement</a>, the company said it does not expect any U.S. drug applications referencing Bendeka until December 2022 and no generic competitors to Treanda until 2022.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362811\" data-linked=\"Court awards Orphan Drug exclusivity for Eagle Pharma&#39;s Bendeka; shares up 6%\" data-tweet=\"$EGRX - Court awards Orphan Drug exclusivity for Eagle Pharma&#39;s Bendeka; shares up 6% https://seekingalpha.com/news/3362811-court-awards-orphan-drug-exclusivity-for-eagle-pharmas-bendeka-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3362811-court-awards-orphan-drug-exclusivity-for-eagle-pharmas-bendeka-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362807\" data-ts=\"1528487706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EOLS\" target=\"_blank\">EOLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362807-profit-taking-pressures-evolus-down-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Profit-taking pressures Evolus, down 18%</a></h4><ul><li>Investors &amp; traders continue to bag profits on Evolus (<a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a> <font color='red'>-17.9%</font>), down on more than triple normal volume. Shares have retraced over&nbsp;<font color='red'>35%</font>&nbsp;since touching $39.50 on Wednesday.</li><li>The stock had rallied four-fold after a brief selloff triggered by the FDA's rejection of its marketing application for Botox competitor prabotulinumtoxinA. Investors jumped into the stock after learning that the rejection related to CMC issues, not safety or efficacy, an issue that should be readily addressable.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3357202-fda-rejects-evolus-marketing-application-prabotulinumtoxina-shares-halted\" target=\"_blank\">FDA rejects Evolus marketing application for prabotulinumtoxinA; shares halted</a> (May 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362807\" data-linked=\"Profit-taking pressures Evolus, down 18%\" data-tweet=\"$EOLS - Profit-taking pressures Evolus, down 18% https://seekingalpha.com/news/3362807-profit-taking-pressures-evolus-down-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3362807-profit-taking-pressures-evolus-down-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362796\" data-ts=\"1528484101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NETE\" target=\"_blank\">NETE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362796-technology-top-5-gainers-losers-of-2_55-pm-06-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (06/08/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/BILI' title='Bilibili'>BILI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/IGLD' title='Internet Gold Golden Lines Ltd.'>IGLD</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/IQ' title='iQIYI, Inc'>IQ</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/TRHC' title='Tabula Rasa HealthCare'>TRHC</a> <font color='green'>+7%</font>.</li>      <li><strong>Losers:</strong> IFON <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/AMRH' title='Ameri Holdings, Inc.'>AMRH</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/NINE' title='Nine Energy Service, Inc.'>NINE</a> <font color='red'>-8%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3362796\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (06/08/2018)\" data-tweet=\"$NETE $NETE $BILI - Technology - Top 5 Gainers / Losers as of 2.55 PM (06/08/2018) https://seekingalpha.com/news/3362796-technology-top-5-gainers-losers-of-2_55-pm-06-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3362796-technology-top-5-gainers-losers-of-2_55-pm-06-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362793\" data-ts=\"1528483364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMASF\" target=\"_blank\">IMASF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362793-inmarsat-rejects-takeover-approach-from-echostar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inmarsat rejects takeover approach from EchoStar</a></h4><ul>   <li>UK-based Inmarsat (<a href=\"http://seekingalpha.com/symbol/IMASF\" target=\"_blank\">IMASF</a> <font color='green'>+38.9%</font>) has <a href=\"https://www.reuters.com/article/us-inmarsat-stocks/inmarsat-rejects-echostar-takeover-bid-says-it-undervalues-firm-idUSKCN1J42EC\" target=\"_blank\">rejected a takeover approach</a> from EchoStar (<a href=\"http://seekingalpha.com/symbol/SATS\" target=\"_blank\">SATS</a> <font color='red'>-1%</font>) on grounds that the deal \"significantly undervalued\" the company.</li>    <li>Shares closed <font color='green'>up 13.5%</font> in London though foreign shares are moving sharply higher on OTC markets.</li>    <li>&ldquo;The board remains highly confident in the independent strategy and prospects of Inmarsat,\" the company says in a statement where it said the proposal didn't properly value Inmarsat's stand-alone prospects.</li>    <li>EchoStar's approach was preliminary and nonbinding, but Inmarsat is waving it off just the same.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362764-ses-europe-satellite-firms-move-fcc-grants-fleet-expansion\" target=\"_blank\">SES up, Europe satellite firms on move after FCC grants fleet expansion</a> (Jun. 08 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3362793\" data-linked=\"Inmarsat rejects takeover approach from EchoStar\" data-tweet=\"$IMASF $IMASF $SATS - Inmarsat rejects takeover approach from EchoStar https://seekingalpha.com/news/3362793-inmarsat-rejects-takeover-approach-from-echostar?source=tweet\" data-url=\"https://seekingalpha.com/news/3362793-inmarsat-rejects-takeover-approach-from-echostar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362792\" data-ts=\"1528483013\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SID\" target=\"_blank\">SID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362792-brazil-resource-names-turn-green-petrobras-eletrobrasplus-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil resource names turn green; Petrobras, Eletrobras +2%</a></h4><ul>     <li>Most U.S.-traded Brazilian resources stocks have turned around from recent losses, as Brazil's central bank chief said the bank would offer up to $20B in currency swaps and <a href=\"https://www.reuters.com/article/emerging-markets-latam/emerging-markets-brazil-equities-slide-cenbank-props-up-currency-idUSL2N1TA102\" target=\"_blank\">ensure liquidity</a> in the currency and interest rate markets.</li><li>In the green: <a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderurgica Nacional'>SID</a> <font color='green'>+2.8%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+0.5%</font>, <a href='https://seekingalpha.com/symbol/BAK' title='Braskem S.A.'>BAK</a> <font color='green'>+3.1%</font>, <a href='https://seekingalpha.com/symbol/GGB' title='Gerdau S.A.'>GGB</a> <font color='green'>+2.9%</font>, <a href='https://seekingalpha.com/symbol/CIG' title='Companhia Energtica de Minas Gerais - CEMIG'>CIG</a> <font color='green'>+4.8%</font>.</li>     <li>Also, J.P. Morgan weighed in with <a href=\"https://seekingalpha.com/news/3362731-brazil-banks-gain-jpmorgan-keeps-overweight-brazil-stocks\" target=\"_blank\">positive comments</a> on the state of affairs in the country and expects accommodative monetary policy until H2 2019.</li>     <li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+2.4%</font>) is higher despite a <a href=\"https://thefly.com/thestreet/realmoney/index.php/PBRid2742666/PBR-Petrobras-downgraded-to-Neutral-at-UBS\" target=\"_blank\">downgrade</a> to Neutral from Buy from UBS after the company recently reduced prices, which the firm says significantly hurt chances of successful selling its refining assets and exposed it to possible interference depending on the government's policy approach and macro conditions.</li>     <li>Even Eletrobras (<a href='https://seekingalpha.com/symbol/EBR' title='Centrais Eletricas Brasileiras S.A. - Eletrobras'>EBR</a> <font color='green'>+1.7%</font>) has pushed into the green despite ongoing setbacks to a privatization program that now seems almost certain to be left to the next government.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWZ' title='iShares MSCI Brazil Capped ETF'>EWZ</a>, <a href='https://seekingalpha.com/symbol/BRZU' title='Direxion Daily Brazil Bull 3x Shares ETF'>BRZU</a>, <a href='https://seekingalpha.com/symbol/BRF' title='VanEck Vectors Brazil Small-Cap ETF'>BRF</a>, <a href='https://seekingalpha.com/symbol/EWZS' title='iShares MSCI Brazil Small-Cap ETF'>EWZS</a>, BZQ-OLD, <a href='https://seekingalpha.com/symbol/BRAQ' title='Global X Brazil Consumer ETF'>BRAQ</a>, <a href='https://seekingalpha.com/symbol/UBR' title='ProShares Ultra MSCI Brazil Capped ETF'>UBR</a>, <a href='https://seekingalpha.com/symbol/BRAZ' title='Global X Brazil Mid-Cap ETF'>BRAZ</a>, <a href='https://seekingalpha.com/symbol/DBBR' title='Deutsche X-trackers MSCI Brazil Hedged Equity ETF'>DBBR</a>, <a href='https://seekingalpha.com/symbol/FBZ' title='First Trust Brazil AlphaDEX ETF'>FBZ</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3362792\" data-linked=\"Brazil resource names turn green; Petrobras, Eletrobras +2%\" data-tweet=\"$SID $SID $VALE - Brazil resource names turn green; Petrobras, Eletrobras +2% https://seekingalpha.com/news/3362792-brazil-resource-names-turn-green-petrobras-eletrobrasplus-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3362792-brazil-resource-names-turn-green-petrobras-eletrobrasplus-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362785\" data-ts=\"1528480867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDT\" target=\"_blank\">SDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362785-energy-materials-top-5-gainers-losers-of-2-00-pm-06-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/08/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SDT' title='SandRidge Mississippian Trust I'>SDT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NXE' title='Nexgen Energy Ltd.'>NXE</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SDR' title='SandRidge Mississippian Trust II'>SDR</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/FTSI' title='FTS International, Inc.'>FTSI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/LBRT' title='Liberty Oilfield Services Inc.'>LBRT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/FET' title='Forum Energy Technologies'>FET</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/RES' title='RPC Inc.'>RES</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362785\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/08/2018)\" data-tweet=\"$SDT $SDT $ANW - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/08/2018) https://seekingalpha.com/news/3362785-energy-materials-top-5-gainers-losers-of-2-00-pm-06-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3362785-energy-materials-top-5-gainers-losers-of-2-00-pm-06-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362781\" data-ts=\"1528478728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATUS\" target=\"_blank\">ATUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362781-altice-usa-completes-separation-from-parent-now-altice-europe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altice USA completes separation from parent, now Altice Europe</a></h4><ul>   <li>Altice USA (<a href=\"http://seekingalpha.com/symbol/ATUS\" target=\"_blank\">ATUS</a> <font color='red'>-1.1%</font>) has completed its official separation from Dutch parent Altice (<a href=\"http://seekingalpha.com/symbol/ALLVF\" target=\"_blank\">ALLVF</a> <font color='red'>-3.1%</font>).</li>    <li>That's happened via an in-kind special distribution of Altice's 67.2% interest in the U.S. spin-off to its shareholders from its share premium reserve. Those shareholders get 0.4163 shares of Altice USA for every share of Altice.</li>    <li>Along with the move, parent Altice NV is changing its name to Altice Europe NV. Patrick Drahi will be executive director of the board at Altice Europe.</li>    <li>Meanwhile, the Altice USA board will consist of nine members, with Drahi serving as chairman. Also on the board will be Charles Stewart (co-president and chief financial officer of Altice USA) and Gerrit Jan Bakker (treasurer of Altice Europe).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3362781\" data-linked=\"Altice USA completes separation from parent, now Altice Europe\" data-tweet=\"$ATUS $ATUS $ALLVF - Altice USA completes separation from parent, now Altice Europe https://seekingalpha.com/news/3362781-altice-usa-completes-separation-from-parent-now-altice-europe?source=tweet\" data-url=\"https://seekingalpha.com/news/3362781-altice-usa-completes-separation-from-parent-now-altice-europe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362779\" data-ts=\"1528478176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNA\" target=\"_blank\">SYNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362779-update-synapticsplus-2-on-potential-dialog-semi-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Update: Synaptics +2% on potential Dialog Semi deal</a></h4><ul><li>Synaptics (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNA' title='Synaptics Incorporated'>SYNA</a>) spikes then falls then bumps up again on <a href=\"https://stocknews.com/news/syna-reports-of-deal-talks-with-dialog-semi/\" target=\"_blank\">social media rumors</a> regarding deal talks with Dialog Semiconductor (<a href='https://seekingalpha.com/symbol/DLGNF' title='Dialog Semiconductor Plc'>OTCPK:DLGNF</a>).</li><li>Synaptics shares are currently&nbsp;<font color='green'>up 0.8%</font>&nbsp;to $42.91.</li><li>Update:<a href=\"https://www.bloomberg.com/news/articles/2018-06-08/dialog-semiconductor-is-said-to-be-in-deal-talks-with-synaptics\" target=\"_blank\"> Bloomberg sources confirm</a> the talks about a potential combination. The exploratory talks might not lead to an agreement.</li><li>Dialog has struggled as Apple cut orders for its power-management chips and a Synaptics tie-up would give the company access to smartphone sensor, touch pad, and touch screen verticals.</li><li>Synaptics shares are now&nbsp;<font color='green'>up 2</font>%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362779\" data-linked=\"Update: Synaptics +2% on potential Dialog Semi deal\" data-tweet=\"$SYNA $SYNA $DLGNF - Update: Synaptics +2% on potential Dialog Semi deal https://seekingalpha.com/news/3362779-update-synapticsplus-2-on-potential-dialog-semi-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3362779-update-synapticsplus-2-on-potential-dialog-semi-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362776\" data-ts=\"1528477234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BFR\" target=\"_blank\">BFR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362776-financials-top-gainers-losers-of-1-00-pm-06-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (06/08/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco FrancÃ©s S.A.  ADR'>BFR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BBDO' title='Banco Bradesco S.A.'>BBDO</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AIHS' title='Senmiao Technology'>AIHS</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362776\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (06/08/2018)\" data-tweet=\"$BFR $BBAR $BBDO - Financials - Top Gainers / Losers as of 1:00 PM (06/08/2018) https://seekingalpha.com/news/3362776-financials-top-gainers-losers-of-1-00-pm-06-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3362776-financials-top-gainers-losers-of-1-00-pm-06-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362770\" data-ts=\"1528476895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESNT\" target=\"_blank\">ESNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362770-essent-group-made-top-idea-zelman-shares-gain-nearly-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Essent Group made a Top Idea at Zelman; shares gain nearly 4%</a></h4><ul><li>No details are available, but Ivy Zelman and team are buying the bounce in mortgage insurer Essent Group (<a href='https://seekingalpha.com/symbol/ESNT' title='Essent Group Ltd.'>ESNT</a> <font color='green'>+3.9%</font>), adding the name to their Top Idea basket.</li><li>At its low for the year in late April, Essent was&nbsp;<font color='red'>down nearly 25%</font>. Shares are now&nbsp;<font color='red'>off about 12%&nbsp;</font>YTYD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362770\" data-linked=\"Essent Group made a Top Idea at Zelman; shares gain nearly 4%\" data-tweet=\"$ESNT - Essent Group made a Top Idea at Zelman; shares gain nearly 4% https://seekingalpha.com/news/3362770-essent-group-made-top-idea-zelman-shares-gain-nearly-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3362770-essent-group-made-top-idea-zelman-shares-gain-nearly-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362769\" data-ts=\"1528476396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCLI\" target=\"_blank\">BCLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362769-brainstorm-cell-files-for-100m-mixed-shelf-offering-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brainstorm Cell files for $100M mixed shelf offering; shares down 4%</a></h4><ul><li>Thinly traded nano cap Brainstorm Cell Therapeutics (<a href='https://seekingalpha.com/symbol/BCLI' title='BrainStorm Cell Therapeutics Inc.'>BCLI</a> <font color='red'>-4.1%</font>) is down on below-average volume on the heels of its <a href=\"https://www.sec.gov/Archives/edgar/data/1137883/000114420418033428/tv495955_s3.htm\" target=\"_blank\">prospectus </a>for a $100M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362769\" data-linked=\"Brainstorm Cell files for $100M mixed shelf offering; shares down 4%\" data-tweet=\"$BCLI - Brainstorm Cell files for $100M mixed shelf offering; shares down 4% https://seekingalpha.com/news/3362769-brainstorm-cell-files-for-100m-mixed-shelf-offering-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3362769-brainstorm-cell-files-for-100m-mixed-shelf-offering-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362768\" data-ts=\"1528476096\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362768-u-s-debuts-worlds-fastest-supercomputer-from-ibm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. debuts &quot;world&#39;s fastest&quot; supercomputer from IBM</a></h4><ul><li>        The U.S. Department of Energy <a href=\"https://www.wsj.com/articles/u-s-says-its-supercomputer-leaps-ahead-of-chinese-rival-1528473600?mod=rss_Technology\" target=\"_blank\">debuts</a> its IBM (<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a> <font color='green'>+0.1%</font>) supercomputer today that it says is the fastest in the world, beating a Chinese machine that&rsquo;s held the top place for two years. A U.S. computer last held the top spot over six years ago. &nbsp;</li><li>        The supercomputer dubbed Summit can perform 200,000 trillion calculations/second, according to IBM, or 200 petaflops. That&rsquo;s eight times more powerful than Cray&rsquo;s (<a href='https://seekingalpha.com/symbol/CRAY' title='Cray Inc'>CRAY</a> <font color='green'>+1.3%</font>) Titan supercomputer and nearly twice as fast as the peak speed for Chinese supercomputer Sunway TaihuLight.</li><li>           Summit is housed at Oak Ridge National Laboratory in Tennessee (the same location as Titan), incorporates technology from Nvidia (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='red'>-0.6%</font>), and cost about $200M.  </li><li>        Summit&rsquo;s uses will include applying machine learning to genetic data to find patterns for treatments for Alzheimer&rsquo;s, heart disease, and opioid addiction and to study supernovas.</li><li>                  The next global ranking of the 500 fastest scientific computers comes on June 25. As of November, China held 202 of the spots compared to 143 for the United States.&nbsp;&nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3344798-cray-ibm-doe-call-supercomputers\" target=\"_blank\">Cray, IBM up after DOE call for supercomputers</a> (April 10)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3345849-hewlett-packard-enterprise-teams-uk-supercomputer-project\" target=\"_blank\">Hewlett Packard Enterprise teams up for UK supercomputer project</a> (April 16)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362768\" data-linked=\"U.S. debuts &quot;world&#39;s fastest&quot; supercomputer from IBM\" data-tweet=\"$IBM $IBM $CRAY - U.S. debuts &quot;world&#39;s fastest&quot; supercomputer from IBM https://seekingalpha.com/news/3362768-u-s-debuts-worlds-fastest-supercomputer-from-ibm?source=tweet\" data-url=\"https://seekingalpha.com/news/3362768-u-s-debuts-worlds-fastest-supercomputer-from-ibm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>106&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362766\" data-ts=\"1528476066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTE\" target=\"_blank\">PTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362766-polarityte-slips-5-on-bearish-citron-tweet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PolarityTE slips 5% on bearish Citron tweet</a></h4><ul><li>Thinly traded small cap PolarityTE (COOL <font color='red'>-4.6%</font>) is down on a 5x surge in volume on the heels of a bearish (what else) <a href=\"https://twitter.com/CitronResearch/status/1005120957600579584\" target=\"_blank\">tweet </a>from short-seller Citron Research.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362766\" data-linked=\"PolarityTE slips 5% on bearish Citron tweet\" data-tweet=\"$PTE - PolarityTE slips 5% on bearish Citron tweet https://seekingalpha.com/news/3362766-polarityte-slips-5-on-bearish-citron-tweet?source=tweet\" data-url=\"https://seekingalpha.com/news/3362766-polarityte-slips-5-on-bearish-citron-tweet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362767\" data-ts=\"1528476015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRKR\" target=\"_blank\">MRKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362767-midday-gainers-losers-06-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (06/08/2018)</a></h4><ul>     <li><strong>Gainers:</strong> TPIV <font color='green'>+71%</font>. <a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a> <font color='green'>+63%</font>. <a href='https://seekingalpha.com/symbol/SVRA' title='Savara Inc.'>SVRA</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NFEC' title='NF Energy Saving Corp.'>NFEC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AZRX' title='AzurRX Biopharma'>AZRX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/VSI' title='Vitamin Shoppe, Inc.'>VSI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ZYME' title='Zymeworks'>ZYME</a> <font color='green'>+13%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='red'>-49%</font>. <a href='https://seekingalpha.com/symbol/ELOX' title='Eloxx Pharmaceuticals, Inc.'>ELOX</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SNES' title='SenesTech'>SNES</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TAX-OLD' title='Liberty Tax, Inc'>TAX-OLD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TOPS' title='TOP Ships Inc.'>TOPS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings'>SGH</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3362767\" data-linked=\"Midday Gainers / Losers (06/08/2018)\" data-tweet=\"$MRKR $MRKR $EDAP - Midday Gainers / Losers (06/08/2018) https://seekingalpha.com/news/3362767-midday-gainers-losers-06-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3362767-midday-gainers-losers-06-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362764\" data-ts=\"1528475501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGBAF\" target=\"_blank\">SGBAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362764-ses-up-europe-satellite-firms-on-move-after-fcc-grants-fleet-expansion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SES up, Europe satellite firms on move after FCC grants fleet expansion</a></h4><ul>   <li>SES Global (<a href='https://seekingalpha.com/symbol/SGBAF' title='Ses Global SA'>OTCPK:SGBAF</a>) is <font color='green'>up 3.1%</font> in OTC trading after getting an OK from the FCC to \"significantly\" <a href=\"https://seekingalpha.com/pr/17186988-u-s-fcc-expands-market-access-ses-o3b-meo-constellation\" target=\"_blank\">expand its O3b satellite fleet</a> in medium earth orbit.</li>    <li>That opens significant additional frequencies that SES will use to serve the U.S. market. A total of 26 new O3b satellites were authorized, adding to 16 already operational and in orbit.</li>    <li>&ldquo;With the first 7 O3b mPOWER satellites, we will deliver a paradigm shift in performance, bandwidth and service,\" says CEO Steve Collar. \"The FCC grant provides the platform to exponentially scale the network in response to surging demand for global data connectivity.&rdquo;</li>    <li>UBS responded by upgrading SES to Buy from Neutral, and made the same move on Eutelsat (<a href=\"http://seekingalpha.com/symbol/ETCMY\" target=\"_blank\">ETCMY</a> <font color='red'>-4.1%</font>).</li>    <li>Inmarsat, meanwhile, is also up (<a href='https://seekingalpha.com/symbol/IMASY' title='Inmarsat Plc. ADR'>OTCPK:IMASY</a> <font color='green'>+14%</font>; <a href='https://seekingalpha.com/symbol/IMASF' title='Inmarsat Plc.'>OTCPK:IMASF</a> <font color='green'>+38.9%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3362764\" data-linked=\"SES up, Europe satellite firms on move after FCC grants fleet expansion\" data-tweet=\"$SGBAF $SGBAF $IMASY - SES up, Europe satellite firms on move after FCC grants fleet expansion https://seekingalpha.com/news/3362764-ses-up-europe-satellite-firms-on-move-after-fcc-grants-fleet-expansion?source=tweet\" data-url=\"https://seekingalpha.com/news/3362764-ses-up-europe-satellite-firms-on-move-after-fcc-grants-fleet-expansion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362762\" data-ts=\"1528475052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362762-nash-players-in-spotlight-on-bristol-myers-squibb-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NASH players in spotlight on Bristol-Myers Squibb interest</a></h4><ul><li>Buying has perked up in certain stocks with exposure to non-alcoholic steatohepatitis &#40;NASH&#41; after Bristol-Myers Squibb's (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='green'>+0.8%</font>) business development chief Paul Biondi said that the company is \"actively looking for acquisitions or license opportunities\" in fibrotic diseases (per DealReporter).</li><li>Selected NASH-related tickers: (<a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color='green'>+0.2%</font>)(<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='green'>+8.7%</font>)(<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='green'>+3.3%</font>)(<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='red'>-1.3%</font>)(<a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+4.6%</font>)(<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color='green'>+1%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='green'>+0.3%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>)(<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='red'>-3.8%</font>)(<a href='https://seekingalpha.com/symbol/GNFTF' title='Genfit'>OTCPK:GNFTF</a> <font color='red'>-1.5%</font>)(<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='green'>+0.6%</font>)(<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a> <font color='green'>+6.7%</font>)(<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+0.4%</font>)(<a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='green'>+2%</font>)(<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color='red'>-5.3%</font>)(<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a> <font color='red'>-3.1%</font>)(<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a>)(<a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a> <font color='green'>+3.9%</font>)(<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a> <font color='green'>+2.8%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='green'>+2%</font>)(<a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='red'>-1%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='red'>-0.1%</font>)(<a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color='red'>-5.5%</font>)(<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color='green'>+6.2%</font>)(<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='red'>-2.6%</font>)(TKPYY <font color='red'>-0.4%</font>)(<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color='red'>-2.4%</font>)(<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color='red'>-0.5%</font>)(<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/ARCT' title='Arcturus Therapeutics Ltd.'>ARCT</a> <font color='red'>-2.8%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362762\" data-linked=\"NASH players in spotlight on Bristol-Myers Squibb interest\" data-tweet=\"$BMY $BMY $CBAY - NASH players in spotlight on Bristol-Myers Squibb interest https://seekingalpha.com/news/3362762-nash-players-in-spotlight-on-bristol-myers-squibb-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3362762-nash-players-in-spotlight-on-bristol-myers-squibb-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>106&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362756\" data-ts=\"1528474046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UBX\" target=\"_blank\">UBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362756-unity-biotechnolog-up-5_2-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Unity Biotechnolog up 5.2% post Q1 results</a></h4><ul><li>Unity Biotechnology (<a href='https://seekingalpha.com/symbol/UBX' title='Unity Biotechnology'>UBX</a> <font color='green'>+5.2%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/4059681\" target=\"_blank\">reports Q</a><a href=\"https://seekingalpha.com/filing/4059681\" target=\"_blank\">1</a> with cash &amp; equivalents of $62.75M (+759.6% Q/Q).</li><li>The increase in cash reflects $54.9M in proceeds from the first close of UNITY&rsquo;s Series C convertible preferred stock financing, offset by $11.9M used in operations &amp; $0.6M in payments related to deferred offering costs from the IPO.</li><li>R&amp;D expenses were $13M (+85.7% Y/Y), the increase was attributable to an increase in personnel related expenses of $3.6M, sponsored research expenses of $1.5M &amp;&nbsp;pre-clinical&nbsp;and&nbsp;start-up&nbsp;activity expenses of $0.9M for the Phase 1 clinical study of UBX0101.</li><li>G&amp;A expenses were $3.5M (+66.7% Y/Y) the increase was due to $0.6M in personnel related expenses and $0.8M increase in professional service expenses in preparation for becoming a public company.</li><li>&ldquo;The company filed first Investigational New Drug application and received clearance from FDA, and are now preparing to enroll the first patients in Phase 1 clinical trial evaluating UBX0101 in moderate to severe osteoarthritis of the knee.&rdquo; said Keith Leonard, chairman &amp; CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362558-unity-biotechnology-reports-q1-results\" target=\"_blank\">Unity Biotechnology reports Q1 results</a> (June 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362756\" data-linked=\"Unity Biotechnolog up 5.2% post Q1 results\" data-tweet=\"$UBX - Unity Biotechnolog up 5.2% post Q1 results https://seekingalpha.com/news/3362756-unity-biotechnolog-up-5_2-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3362756-unity-biotechnolog-up-5_2-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362758\" data-ts=\"1528474003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELOX\" target=\"_blank\">ELOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362758-eloxx-pharmas-elxminus-02-shows-encouraging-action-in-preclinical-cf-studies-investors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eloxx Pharma&#39;s ELX-02 shows encouraging action in preclinical CF studies; investors unmoved, shares down 11%</a></h4><ul><li>Investors appear unimpressed with <a href=\"https://seekingalpha.com/pr/17187333-eloxx-pharmaceuticals-presents-positive-new-data-lead-investigational-drug-elxminus-02-41st\" target=\"_blank\">preclinical data</a> on Eloxx Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/ELOX' title='Eloxx Pharmaceuticals, Inc.'>ELOX</a> <font color='red'>-10.6%</font>) lead candidate ELX-02 for the treatment of certain cystic fibrosis &#40;CF&#41; patients. The results were presented at the European Cystic Fibrosis Conference in Belgrade.</li><li>When tested on organoids (mass of cells/tissue resembling an organ) from CF patients with homozygous and compound heterozygous nonsense mutations, ELX-02 induced an increase in forskolin-induced swelling &#40;FIS&#41; (a surrogate for clinical response to the drug) in a dose-dependent manner. FIS has been shown to correlate with improvement in lung function as measured by FEV1 (amount of air that can be exhaled in one breath).</li><li>Other preclinical data, generated on Fisher Rat Thyroid cells, human bronchi epithelium cells and in a mouse model, showed potentially clinically relevant responses.</li><li>The company believes that small molecule ELX-02, an aminoglycoside antibiotic, can benefit CF patients who have nonsense mutations on the CFTR gene, representing ~13% of all CF sufferers, because it has a high \"read-through\" (transcription of nucleic acid sequence) for such mutations.</li><li>A Phase 2 clinical trial in CF patients with at least one mutation, called G542X, should launch later this year.</li><li>Selected CF-related tickers: (<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color='green'>+2.1%</font>)(<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='green'>+0.5%</font>)(<a href='https://seekingalpha.com/symbol/VRNA' title='Verona Pharma plc'>VRNA</a> <font color='green'>+3.4%</font>)(<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='green'>+0.5%</font>)(<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a> <font color='red'>-0.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362758\" data-linked=\"Eloxx Pharma&#39;s ELX-02 shows encouraging action in preclinical CF studies; investors unmoved, shares down 11%\" data-tweet=\"$ELOX $ELOX $VRTX - Eloxx Pharma&#39;s ELX-02 shows encouraging action in preclinical CF studies; investors unmoved, shares down 11% https://seekingalpha.com/news/3362758-eloxx-pharmas-elxminus-02-shows-encouraging-action-in-preclinical-cf-studies-investors?source=tweet\" data-url=\"https://seekingalpha.com/news/3362758-eloxx-pharmas-elxminus-02-shows-encouraging-action-in-preclinical-cf-studies-investors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362749\" data-ts=\"1528473949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HURC\" target=\"_blank\">HURC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362749-on-hurco-companies-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Hurco Companies Q2 results</a></h4><ul><li>Hurco Companies (<a href='https://seekingalpha.com/symbol/HURC' title='Hurco Companies, Inc.'>HURC</a> <font color='red'>-2.6%</font>) reported Q2 net sales growth of 21% Y/Y to $70.24M reflecting favorable impact from forex (8%).</li><li>Sales by geography: Americas $21.65M (+20% Y/Y), Europe $38.24M (+21% Y/Y) and Asia Pacific $10.53M (+22% Y/Y).</li><li>Q2 Margins: Gross&nbsp;<font color='red'>declined by 189 bps</font>&nbsp;to 27.4% and operating&nbsp;<font color='red'>declined by 69 bps</font>&nbsp;to 8.5%.</li><li>SG&amp;A expenses increased 13.7% Y/Y to $13.32M, driven by unfavorable currency impacts.</li><li>Orders for Q2 increased by 26% Y/Y to $79.92M reflecting increased customer demand for Hurco and Takumi vertical milling machines in&nbsp;Germany&nbsp;and the&nbsp;United Kingdom, and also increased customer demand for machine tool components and accessories.</li><li>Orders by geography: Americas $20.87M (+13% Y/Y), Europe $46.08M (+41% Y/Y) and Asia Pacific $12.97M (+5% Y/Y).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362642-hurco-reports-q2-results\" target=\"_blank\">Hurco reports Q2 results</a> (June 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362749\" data-linked=\"More on Hurco Companies Q2 results\" data-tweet=\"$HURC - More on Hurco Companies Q2 results https://seekingalpha.com/news/3362749-on-hurco-companies-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3362749-on-hurco-companies-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362753\" data-ts=\"1528473679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REV\" target=\"_blank\">REV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362753-consumer-top-gainers-losers-of-12-00-pm-06-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (06/08/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GPRO' title='GoPro'>GPRO</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362753\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (06/08/2018)\" data-tweet=\"$REV $REV $FNKO - Consumer - Top Gainers / Losers as of 12:00 PM (06/08/2018) https://seekingalpha.com/news/3362753-consumer-top-gainers-losers-of-12-00-pm-06-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3362753-consumer-top-gainers-losers-of-12-00-pm-06-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362751\" data-ts=\"1528473338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362751-workday-acquires-talent-agency-platform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday acquires talent agency platform</a></h4><ul><li>        Workday (NYSE:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a>) <a href=\"https://techcrunch.com/2018/06/08/workday-acquires-rallyteam-to-fuel-machine-learning-efforts/\" target=\"_blank\">acquires</a> talent agency platform Rallyteam for an undisclosed amount.</li><li>               Rallyteam helps companies retain employees by matching talented workers with in-house opportunities.&nbsp;</li><li>               TechCrunch says Workday likely wants Rallyteam&rsquo;s workers to bolster Workday&rsquo;s machine learning efforts.&nbsp;</li><li>               Rallyteam was founded in 2013 and last fall raised $8.6M in a round led by Norwest Ventures with participation from Cornerstone OnDemand, Storm Ventures, and Wilson Sonsini.&nbsp;</li><li>               Workday shares are&nbsp;<font color='green'>up 0.7%</font>&nbsp;to $124.28.&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3362751\" data-linked=\"Workday acquires talent agency platform\" data-tweet=\"$WDAY - Workday acquires talent agency platform https://seekingalpha.com/news/3362751-workday-acquires-talent-agency-platform?source=tweet\" data-url=\"https://seekingalpha.com/news/3362751-workday-acquires-talent-agency-platform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362743\" data-ts=\"1528472293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGHSF\" target=\"_blank\">EGHSF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362743-enghouse-systems-up-3_9-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enghouse Systems up 3.9% post Q2 results</a></h4><ul><li>Enghouse Systems (<a href='https://seekingalpha.com/symbol/EGHSF' title='Enghouse Systems Ltd.'>OTCPK:EGHSF</a>)&nbsp;<a href=\"https://www.enghouse.com/news/2018/Q2\" target=\"_blank\">reports Q2</a>&nbsp;revenue growth of 7.1% Y/Y to C$85.2M.</li><li>Segment revenue: Software licenses of C$24.7M (+3.8% Y/Y); Hosted and maintenance services C$43.9M (+10% Y/Y); Professional services C$14.5M (-2.7% Y/Y) &amp; Hardware C$2.1M (+110% Y/Y).</li><li>Adj. EBITDA&nbsp;<font color='green'>increased 110 bps</font>&nbsp;to 29.8% &amp; income from operating activities was C$24.7M (+12.8% Y/Y).</li><li>The company approved its quarterly dividend of C$0.18 per common share.</li><li>CFO was C$21.8M (+18.5% Y/Y) &amp; cash &amp; equivalents of C$145.6M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362566-enghouse-systems-reports-q2-results\" target=\"_blank\">Enghouse Systems reports Q2 results</a> (June 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362743\" data-linked=\"Enghouse Systems up 3.9% post Q2 results\" data-tweet=\"$EGHSF - Enghouse Systems up 3.9% post Q2 results https://seekingalpha.com/news/3362743-enghouse-systems-up-3_9-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3362743-enghouse-systems-up-3_9-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362742\" data-ts=\"1528472082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGH\" target=\"_blank\">SGH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362742-smart-global-holdingsminus-9_4-on-brazilian-real-struggles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SMART Global Holdings -9.4% on Brazilian real struggles</a></h4><ul><li>        Brazil-focused DRAM company SMART Global Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings'>SGH</a>)&nbsp;<font color='red'>plunges 9.4%</font>&nbsp;due to the struggling Brazilian real.</li><li>                  Central bank intervention to support the real failed.    </li><li>               SMART shares are&nbsp;<font color='green'>up 2%</font>&nbsp;this week,&nbsp;<font color='green'>3.5%</font>&nbsp;in the past month, and&nbsp;<font color='green'>35%</font>&nbsp;YTD. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362430-brazil-banks-tank-central-bank-intervention-fails-prop-real\" target=\"_blank\">Brazil banks tank as central bank intervention fails to prop up real</a> (June 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362742\" data-linked=\"SMART Global Holdings -9.4% on Brazilian real struggles\" data-tweet=\"$SGH - SMART Global Holdings -9.4% on Brazilian real struggles https://seekingalpha.com/news/3362742-smart-global-holdingsminus-9_4-on-brazilian-real-struggles?source=tweet\" data-url=\"https://seekingalpha.com/news/3362742-smart-global-holdingsminus-9_4-on-brazilian-real-struggles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362738\" data-ts=\"1528471158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362738-qualcomm-extends-tender-offer-for-nxp-tendered-shares-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm extends tender offer for NXP, tendered shares drop</a></h4><ul><li>        Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) again extends its tender offer from NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>). The new expiration date is June 15.</li><li>               The tendered shares count stands at about 17.7M or 5.1% of the outstanding NXP shares, down from the 16.2% and the 13.1% tendered as of the last extensions.&nbsp;</li><li>               Qualcomm shares are&nbsp;<font color='red'>down 0.5%</font>&nbsp;to $60.34.&nbsp;</li><li>               NXP shares are<font color='red'> down 0.2%</font>&nbsp;to $119.84. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3355967-qualcomm-extends-nxp-tender-may-25-tendered-shares-drop\" target=\"_blank\">Qualcomm extends NXP tender to May 25; tendered shares drop</a> (May 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362738\" data-linked=\"Qualcomm extends tender offer for NXP, tendered shares drop\" data-tweet=\"$QCOM $QCOM $NXPI - Qualcomm extends tender offer for NXP, tendered shares drop https://seekingalpha.com/news/3362738-qualcomm-extends-tender-offer-for-nxp-tendered-shares-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3362738-qualcomm-extends-tender-offer-for-nxp-tendered-shares-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362736\" data-ts=\"1528470820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DARE\" target=\"_blank\">DARE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362736-dar-bio-trying-to-clear-near-term-consolidation-up-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DarÃ© Bio trying to clear near-term consolidation, up 14%</a></h4><ul><li>Nano cap Dar&eacute; Bioscience (<a href='https://seekingalpha.com/symbol/DARE' title='Dare Bioscience, Inc.'>DARE</a> <font color='green'>+13.6%</font>) broke through the $1.50 high of a six-week base in early trade but is struggling to maintain the breakout. Shares are now exchanging hands at $1.50, down 9% from the intraday high of $1.65.</li><li>Shares initially rallied in late April on the news that the company secured exclusive rights to Juniper Pharmaceuticals' contraceptive intravaginal ring technology. In mid-May, it <a href=\"https://seekingalpha.com/pr/17163382-dare-bioscience-inc-announces-trial-initiation-ovaprene-non-hormonal-monthly-contraceptive\" target=\"_blank\">launched </a>a study evaluating its own contraceptive vaginal ring, Ovaprene, for post-coital use.</li><li>In early May, it <a href=\"https://seekingalpha.com/pr/17153736-dare-bioscience-inc-enters-agreement-acquire-product-address-vulvar-vaginal-atrophy-hormone\" target=\"_blank\">announced </a>a merger with Pear Tree Pharmaceuticals aimed at gaining ownership of PT-101, a vaginal formulation of tamoxifen for the potential treatment of vulvar and vaginal atrophy in certain breast cancer patients.</li><li>On the financial front, at the end of March it had $15.6M in cash and equivalents while operations consumed $2.1M in Q1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362736\" data-linked=\"DarÃ© Bio trying to clear near-term consolidation, up 14%\" data-tweet=\"$DARE - DarÃ© Bio trying to clear near-term consolidation, up 14% https://seekingalpha.com/news/3362736-dar-bio-trying-to-clear-near-term-consolidation-up-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3362736-dar-bio-trying-to-clear-near-term-consolidation-up-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362732\" data-ts=\"1528470032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDAP\" target=\"_blank\">EDAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362732-healthcare-top-5-gainers-losers-of-11-00-06-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/08/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a> <font color='green'>+70%</font>. TPIV <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/SVRA' title='Savara Inc.'>SVRA</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/DARE' title='Dare Bioscience, Inc.'>DARE</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='red'>-55%</font>. <a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics'>CODX</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362732\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/08/2018)\" data-tweet=\"$EDAP $EDAP $MRKR - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/08/2018) https://seekingalpha.com/news/3362732-healthcare-top-5-gainers-losers-of-11-00-06-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3362732-healthcare-top-5-gainers-losers-of-11-00-06-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362726\" data-ts=\"1528468781\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACOR\" target=\"_blank\">ACOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362726-acorda-adds-to-rally-up-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acorda adds to rally, up 24%</a></h4><ul><li>Thinly traded Acorda Therapeutics (<a href='https://seekingalpha.com/symbol/ACOR' title='Acorda Therapeutics, Inc.'>ACOR</a> <font color='green'>+23.8%</font>) is up again on almost a 6x surge in volume. Shares have rallied&nbsp;<font color='green'>50%</font>&nbsp;since May 23.</li><li>The company's appeal of an adverse patent ruling for top-seller Ampyra (dalfampridine) was reportedly scheduled to start June 7.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3272578-acorda-continues-defense-ampyra-patents-generic-competitors-appeals-adverse-lower-court\" target=\"_blank\">Acorda continues its defense of Ampyra patents against generic competitors, appeals adverse lower court decision</a> (June 9, 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3254831-court-invalidates-four-ampyra-patents-acorda-plummets-24-percent\" target=\"_blank\">Court invalidates four Ampyra patents; Acorda plummets 24%</a> (March 31, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362726\" data-linked=\"Acorda adds to rally, up 24%\" data-tweet=\"$ACOR - Acorda adds to rally, up 24% https://seekingalpha.com/news/3362726-acorda-adds-to-rally-up-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3362726-acorda-adds-to-rally-up-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362724\" data-ts=\"1528468238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBVX\" target=\"_blank\">MBVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362724-mabvax-up-26\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MabVax up 26%</a></h4><ul><li>Thinly traded nano cap MabVax Therapeutics Holdings (<a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='green'>+25.5%</font>) is up on a 21x surge in volume early in the session. No particular news accounts for action. Shares had sold off over&nbsp;<font color='red'>50%</font>&nbsp;since touching $2.18 on May 17 before buying picked up.</li><li>Recently, the company received notices from the SEC related to potential <a href=\"https://www.sec.gov/Archives/edgar/data/1109196/000165495418005675/mbvx8k_may212018.htm\" target=\"_blank\">disclosure violations</a> by preferred stockholders and its <a href=\"https://www.sec.gov/Archives/edgar/data/1109196/000165495418005846/mbvx_ex991.htm\" target=\"_blank\">delayed filing </a>of its most recent 10-Q.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358281-mabvax-27-percent-accuracy-issues-prior-financials\" target=\"_blank\">MabVax down 27% on accuracy issues in prior financials</a> (May 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362724\" data-linked=\"MabVax up 26%\" data-tweet=\"$MBVX $MBVXQ - MabVax up 26% https://seekingalpha.com/news/3362724-mabvax-up-26?source=tweet\" data-url=\"https://seekingalpha.com/news/3362724-mabvax-up-26\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362723\" data-ts=\"1528468020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362723-amdplus-1_4-on-information-report-intel-battle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD +1.4% on The Information report about Intel battle</a></h4><ul><li>        Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) gains on a <a href=\"https://www.theinformation.com/articles/intels-manufacturing-glitch-opens-door-for-amd\" target=\"_blank\">The Information</a> report about how Intel&rsquo;s (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-1.3%</font>) manufacturing glitch opens the way for AMD to become first to market with a new, advanced chip.</li><li>               Intel announced in April that the mass production of its 10nm Cannon Lake chips would receive another delay that would push the release back from the end of this year to 2019.&nbsp;</li><li>               AMD shares are<font color='green'>&nbsp;up 1.4%</font>&nbsp;to $15.10.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362092-amd-plus-5_5-percent-7nm-gpu-unveil-nvidia-ceo-comments\" target=\"_blank\">AMD +5.5% after 7nm GPU unveil, Nvidia CEO comments</a> (June 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3349984-intel-erases-post-earnings-gains-delays-cannon-lake\" target=\"_blank\">Intel erases post-earnings gains, delays Cannon Lake again</a> (April 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362723\" data-linked=\"AMD +1.4% on The Information report about Intel battle\" data-tweet=\"$AMD $AMD $INTC - AMD +1.4% on The Information report about Intel battle https://seekingalpha.com/news/3362723-amdplus-1_4-on-information-report-intel-battle?source=tweet\" data-url=\"https://seekingalpha.com/news/3362723-amdplus-1_4-on-information-report-intel-battle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>102&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362720\" data-ts=\"1528467883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VISI\" target=\"_blank\">VISI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362720-volt-information-sciences-up-2-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volt Information Sciences up 2% post Q2 results</a></h4><ul><li>Volt Information Sciences (<a href='https://seekingalpha.com/symbol/VISI' title='Volt Information Sciences, Inc.'>VISI</a> <font color='green'>+1.7%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/4059347\" target=\"_blank\">reports Q2</a>&nbsp;revenue decrease of 13.1% Y/Y to $263.2M.</li><li>Segment revenue: North American Staffing of $218.1M (-6.7% Y/Y); International Staffing $31.9M (+5.6% Y/Y); Corporate and Other $14.2M (-64.9% Y/Y).</li><li>On a same-store basis, net revenue declined 7.8% Y/Y, excluding net revenue contributed from businesses sold or exited during the past year and the effect of currency fluctuations.</li><li>Selling, administrative &amp; other operating costs of $42.9M (-16.1% Y/Y) &amp; Adjusted EBITDA -$3.7M, up $1.8M Y/Y.</li><li>Global liquidity of $59.4M, up $3.5M Y/Y; Total outstanding debt of $50M, down $40M Y/Y.</li><li>The Company announced that President and CEO Michael Dean left the Company &amp; also announced that Linda Perneau was appointed Interim Chief Executive Officer, in addition to her role as President of Volt Workforce Solutions.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362516-volt-information-sciences-reports-q2-results\" target=\"_blank\">Volt Information Sciences reports Q2 results</a> (June 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362720\" data-linked=\"Volt Information Sciences up 2% post Q2 results\" data-tweet=\"$VISI $VOLT - Volt Information Sciences up 2% post Q2 results https://seekingalpha.com/news/3362720-volt-information-sciences-up-2-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3362720-volt-information-sciences-up-2-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362704\" data-ts=\"1528467877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362704-buyout-chatter-lifts-intercept-pharma-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buyout chatter lifts Intercept Pharma more than 6%</a></h4><ul><li><a href=\"https://www.dealreporter.com/info/\" target=\"_blank\">Dealreporter is talking</a> about Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='green'>+0.3%</font>) having interest in purchasing Intercept Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='green'>+6.2%</font>).</li><li><strong>Update at 10:25 ET</strong> via Bloomberg: Dealreporter reports BMY business development chief Paul Biondi as saying his company is actively looking for acquisition or license opportunities in fibrotic diseases. Also on the move are Madrigal Pharma (<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color='green'>+4.8%</font>), Viking Therapeutics (<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color='green'>+1.7%</font>), Reata Pharma (<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color='green'>+1%</font>), Galapagos (<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a> <font color='green'>+0.2%</font>), and FibroGen (<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen'>FGEN</a> <font color='green'>+1.8%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3362704\" data-linked=\"Buyout chatter lifts Intercept Pharma more than 6%\" data-tweet=\"$BMY $BMY $ICPT - Buyout chatter lifts Intercept Pharma more than 6% https://seekingalpha.com/news/3362704-buyout-chatter-lifts-intercept-pharma-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3362704-buyout-chatter-lifts-intercept-pharma-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362712\" data-ts=\"1528467500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPST\" target=\"_blank\">CPST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362712-capstone-turbine-down-8-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capstone Turbine down 8% post Q4 results</a></h4><ul><li>Capstone Turbine (<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a> <font color='red'>-8.8%</font>) reported Q4 revenue of $21.1M (-7.9% Y/Y). Segment revenues: Microturbine products $11.5M (-24.3% Y/Y) and accessories parts &amp; services $9.6M (+23.1% Y/Y).</li><li>Q4 gross margin<font color='green'> improved by 1,340 bps</font>&nbsp;to 23%, the highest in the company history.</li><li>Q4 expenses: R&amp;D $0.8M (-27.27% Y/Y) and SG&amp;A $5.8M (+13.7% Y/Y).</li><li>Company recorded Q4 aftermarket gross margin of ~45% for accessories, parts &amp; services segments, which helped cover 77% of the company&rsquo;s operating expenses.</li><li>Company reported a positive Adj. EBITDA of $0.1M in contrast to year-ago EBITDA loss of $3.5M.</li><li>Cash from operating activities was $500K.</li><li>Q4 product order book-to-bill ratio was 1.4:1, strongest in last 4 years and Backlog was ~$97.3M as of March 31, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362531-capstone-turbine-beats-0_02-misses-revenue\" target=\"_blank\">Capstone Turbine beats by $0.02, misses on revenue</a> (June 7)</li><li><a href=\"https://seekingalpha.com/article/4180195-capstone-turbine-corporation-2018-q4-results-earnings-call-slides\" target=\"_blank\">Slides</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3362712\" data-linked=\"Capstone Turbine down 8% post Q4 results\" data-tweet=\"$CPST - Capstone Turbine down 8% post Q4 results https://seekingalpha.com/news/3362712-capstone-turbine-down-8-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3362712-capstone-turbine-down-8-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362719\" data-ts=\"1528467453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPST\" target=\"_blank\">CPST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362719-capstone-turbineminus-8-after-incomplete-quarterly-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capstone Turbine -8% after incomplete quarterly results</a></h4><ul>     <li>Capstone Turbine (<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a> <font color='red'>-8.8%</font>) tumbles in early trade after reporting a <a href=\"https://seekingalpha.com/news/3362531-capstone-turbine-beats-0_02-misses-revenue\" target=\"_blank\">$0.20 FY 2018 loss</a> vs. a $0.79 loss in the prior year, with revenues +7%&nbsp;Y/Y to nearly $83M, but the company does not issue earnings or revenue results for the latest quarter.</li>     <li>Among FQ4 highlights that are presented: 23% total gross margin is highest in company history, 1.4:1 book-to-bill ratio is the strongest since Q2 2014, and adjusted EBITDA came in positive for the second straight quarter.</li>     <li>Adjusted EBITDA for FY 2018 was -$5.2M, or a $0.10/share loss, vs. year-ago adjusted EBITDA of -$21.9M, or a $0.68/share loss.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362719\" data-linked=\"Capstone Turbine -8% after incomplete quarterly results\" data-tweet=\"$CPST - Capstone Turbine -8% after incomplete quarterly results https://seekingalpha.com/news/3362719-capstone-turbineminus-8-after-incomplete-quarterly-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3362719-capstone-turbineminus-8-after-incomplete-quarterly-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362718\" data-ts=\"1528467116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOVA\" target=\"_blank\">DOVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362718-another-insider-buy-dova-pharma-shares-up-3_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another insider buy at Dova Pharma; shares up 3.3%</a></h4><ul><li>Board member Paul Manning <a href=\"https://seekingalpha.com/filing/4060332\" target=\"_blank\">this week purchased</a> 27K shares at an average price of $27.78 each. The buys totaled $767K and boosted his holdings by 0.2%.</li><li>Full <a href=\"http://www.insiderinsights.com/company/DOVA/dova-pharmaceuticals-inc\" target=\"_blank\">insider history</a> and performance statistics/past trades <a href=\"http://www.insiderinsights.com/insider/1494695/manning-paul-b\" target=\"_blank\">by Paul Manning</a> are available at InsiderInsights.</li><li><a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals'>DOVA</a>&nbsp;<font color='green'>+3.3%</font>&nbsp;today to $28.08</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362055-dova-pharma-another-8-percent-insiders-buy\" target=\"_blank\">Dova Pharma up another 8% as insiders buy</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362718\" data-linked=\"Another insider buy at Dova Pharma; shares up 3.3%\" data-tweet=\"$DOVA - Another insider buy at Dova Pharma; shares up 3.3% https://seekingalpha.com/news/3362718-another-insider-buy-dova-pharma-shares-up-3_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3362718-another-insider-buy-dova-pharma-shares-up-3_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362717\" data-ts=\"1528467099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362717-tech-sector-under-pressure-from-apple-suppliers-semi-equipment-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech sector under pressure from Apple suppliers, semi equipment stocks</a></h4><ul><li>           Semiconductor stocks and Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='red'>-1.6%</font>) suppliers are pulling the tech industry down on today&rsquo;s open after Broadcom&rsquo;s (<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a> <font color='red'>-2.1%</font>), TSMC&rsquo;s (<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a> <font color='red'>-1.8%</font>) May revenue report, and a report that Apple could drop supplier orders by 20%. Semiconductor equipment makers remain pressured from yesterday&rsquo;s analyst comment about memory push-outs. </li><li>           The Philadelphia Semiconductor Index is down 1% and the sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) is down 0.5%.  </li><li> Apple suppliers on the move: Cirrus Logic (<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color='red'>-2.8%</font>), Finisar (<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a> <font color='red'>-3%</font>), II-VI (<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a> <font color='green'>+0.9%</font>), Lumentum (<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='red'>-5.4%</font>), Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='red'>-1.4%</font>), Skyworks Solutions (<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a> <font color='red'>-2.5%</font>), STMicroelectronics (<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a> <font color='red'>-1.1%</font>), Universal Display (<a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='red'>-2.2%</font>). </li><li> Semi equipment movers: Applied Materials (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color='red'>-1%</font>), &nbsp;ASML (<a href='https://seekingalpha.com/symbol/ASML' title='ASML Holding N.V.'>ASML</a> <font color='red'>-0.5%</font>), KLA-Tencor (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a> <font color='red'>-1.6%</font>), Ichor (<a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='red'>-1.2%</font>), Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='red'>-0.9%</font>), Ultra Clean Holdings (<a href='https://seekingalpha.com/symbol/UCTT' title='Ultra Clean Holdings, Inc.'>UCTT</a> <font color='red'>-1.5%</font>), Brooks Automation (<a href='https://seekingalpha.com/symbol/BRKS' title='Brooks Automation, Inc.'>BRKS</a> <font color='red'>-0.3%</font>), AXT (<a href='https://seekingalpha.com/symbol/AXTI' title='AXT Inc'>AXTI</a> <font color='red'>-3.2%</font>), Nanometrics (<a href='https://seekingalpha.com/symbol/NANO' title='Nanometrics Incorporated'>NANO</a> <font color='red'>-3.3%</font>), Nova Measuring Instruments (<a href='https://seekingalpha.com/symbol/NVMI' title='Nova Measuring Instruments Ltd.'>NVMI</a> <font color='red'>-1.1%</font>), Axcelis Technologies (<a href='https://seekingalpha.com/symbol/ACLS' title='Axcelis Technologies, Inc.'>ACLS</a> <font color='red'>-0.5%</font>), Ambarella (<a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a> <font color='red'>-0.9%</font>), Synopsys (<a href='https://seekingalpha.com/symbol/SNPS' title='Synopsys, Inc.'>SNPS</a>), and Teradyne (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne Inc.'>TER</a> <font color='red'>-1.5%</font>). </li><li> Other semiconductor companies on the move: Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-1%</font>), Cavium (CAVM <font color='red'>-0.9%</font>), Analog Devices (<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a> <font color='red'>-1%</font>), Xilinx (<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a> <font color='red'>-1.3%</font>), &nbsp;Marvell Technology (<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a> <font color='red'>-1.7%</font>), AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+0.8%</font>).&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3362529-broadcom-beats-q2-healthy-wireless-storage-growth\" target=\"_blank\">Broadcom beats in Q2 with healthy wireless, storage growth</a> (June 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362378-lam-research-minus-5_7-percent-analyst-cautions-shipments\" target=\"_blank\">Lam Research -5.7% as analyst cautions on shipments</a> (June 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362403-semi-equipment-stocks-drop-analyst-warning-memory-push-outs\" target=\"_blank\">Semi equipment stocks drop on analyst warning about memory push-outs</a> (June 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362628-tsmc-minus-2_6-percent-soft-may-revenue\" target=\"_blank\">TSMC -2.6% on soft May revenue</a> (June 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362639-nar-apple-drops-iphone-parts-orders-20-percent-supplier-stocks-dip\" target=\"_blank\">NAR: Apple drops iPhone parts orders by 20%; supplier stocks dip</a> (June 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362717\" data-linked=\"Tech sector under pressure from Apple suppliers, semi equipment stocks\" data-tweet=\"$AAPL $AAPL $AVGO - Tech sector under pressure from Apple suppliers, semi equipment stocks https://seekingalpha.com/news/3362717-tech-sector-under-pressure-from-apple-suppliers-semi-equipment-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3362717-tech-sector-under-pressure-from-apple-suppliers-semi-equipment-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362716\" data-ts=\"1528467036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAX-OLD\" target=\"_blank\">TAX-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362716-liberty-tax-falls-after-disclosing-accounting-firm-resignation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liberty Tax falls after disclosing accounting firm resignation</a></h4><ul> <li>Liberty Tax (NASDAQ:<a href='https://seekingalpha.com/symbol/TAX-OLD' title='Liberty Tax, Inc'>TAX-OLD</a>) is <font color='red'>down 12%</font> in early trading to drop back below $10 for the first time since late April.</li> <li>The selling action may be tied to a SEC filing from the company on the resignation of its public accounting firm on June 5.</li> <li><a href=\"https://seekingalpha.com/filing/4059390\" target=\"_blank\">SEC Form 8-K</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3362716\" data-linked=\"Liberty Tax falls after disclosing accounting firm resignation\" data-tweet=\"$TAX-OLD - Liberty Tax falls after disclosing accounting firm resignation https://seekingalpha.com/news/3362716-liberty-tax-falls-after-disclosing-accounting-firm-resignation?source=tweet\" data-url=\"https://seekingalpha.com/news/3362716-liberty-tax-falls-after-disclosing-accounting-firm-resignation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362709\" data-ts=\"1528466590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362709-savara-up-23-on-bullish-evercore-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Savara up 23% on bullish Evercore call</a></h4><ul><li>Thinly traded micro cap Savara (<a href='https://seekingalpha.com/symbol/SVRA' title='Savara Inc.'>SVRA</a> <font color='green'>+22.5%</font>) is up on modestly higher volume on the heels of a bullish call from Evercore ISI. Analyst Josh Schimmer (Outperform/$40) sees over 250% upside in the stock.</li><li>The company's lead drug is Molgradex, in Phase 2 development for the treatment of nontuberculous mycobacterial lung infection. Preliminary data from the open-label study, called <a href=\"https://clinicaltrials.gov/ct2/show/NCT03421743?term=savara&amp;rank=2\" target=\"_blank\">OPTIMA</a>, may be available later this year.</li><li>On May 29, the company <a href=\"https://seekingalpha.com/pr/17175623-savara-provides-update-case-reports-inhaled-granulocyte-macrophage-colony-stimulating-factor\" target=\"_blank\">announced</a> the details from two case reports of cystic fibrosis patients treated with Molgradex, an aerosolized granulocyte-macrophage colony stimulating factor, who had lung infections due to <em>Mycobacterium abscessus</em>, a species of multidrug-resistant nontuberculous mycobacteria. Molgradex eradicated the bug in one patient and elicited a \"strong microbiological response\" in the other. Both patients experienced meaningful improvements in weight gain and lung function.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3338698-savara-launches-mid-stage-study-lead-candidate-lung-infection\" target=\"_blank\">Savara launches mid-stage study of lead candidate in lung infection</a> (March 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362709\" data-linked=\"Savara up 23% on bullish Evercore call\" data-tweet=\"$SVRA - Savara up 23% on bullish Evercore call https://seekingalpha.com/news/3362709-savara-up-23-on-bullish-evercore-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3362709-savara-up-23-on-bullish-evercore-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362703\" data-ts=\"1528465618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSHB\" target=\"_blank\">KSHB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362703-kush-bottles-down-nearly-20-after-equity-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kush Bottles down nearly 20% after equity raise</a></h4><ul><li>The company has agreed to the sale of 7.5M shares of common stock and 3.75M warrants at a combined offering price of $4.80 per share. The warrants are struck at $5.28.</li><li>Gross proceeds are about $36M.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17187115-kush-bottles-inc-prices-36000-000-registered-direct-offering\" target=\"_blank\">Press Release</a></li><li><a href='https://seekingalpha.com/symbol/KSHB' title='KushCo Holdings, Inc.'>OTCQB:KSHB</a><font color='red'> -19.25%</font>&nbsp;to $5.41</li></ul><div class=\"tiny-share-widget\" data-id=\"3362703\" data-linked=\"Kush Bottles down nearly 20% after equity raise\" data-tweet=\"$KSHB - Kush Bottles down nearly 20% after equity raise https://seekingalpha.com/news/3362703-kush-bottles-down-nearly-20-after-equity-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3362703-kush-bottles-down-nearly-20-after-equity-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362693\" data-ts=\"1528464465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRKR\" target=\"_blank\">MRKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362693-tapimmune-prices-70m-private-stock-deal-4-shares-down-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TapImmune prices $70M private stock deal at $4; shares down 9% premarket</a></h4><ul><li>TapImmune (TPIV) slips&nbsp;<font color='red'>9%&nbsp;</font>premarket on the heels of its announced <a href=\"https://seekingalpha.com/pr/17187254-tapimmune-announces-pricing-70-million-private-placement\" target=\"_blank\">private placement</a> of 17.5M common shares at $4/share. Investors will also receive five-year warrants to purchase up to 13.125M shares at $5.</li><li>The transaction should close by the end of next quarter.</li><li>Yesterday's close was $5.95.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362693\" data-linked=\"TapImmune prices $70M private stock deal at $4; shares down 9% premarket\" data-tweet=\"$MRKR - TapImmune prices $70M private stock deal at $4; shares down 9% premarket https://seekingalpha.com/news/3362693-tapimmune-prices-70m-private-stock-deal-4-shares-down-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3362693-tapimmune-prices-70m-private-stock-deal-4-shares-down-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362692\" data-ts=\"1528464382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBLK\" target=\"_blank\">CBLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362692-analyst-raise-carbon-black-targets-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analyst raise Carbon Black targets after earnings</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Carbon+Black+Inc+%28CBLK%29+PT+Raised+to+%2424+at+Morgan+Stanley/14288039.html\" target=\"_blank\">maintains</a> an Equal Weight rating for Carbon Black (NASDAQ:<a href='https://seekingalpha.com/symbol/CBLK' title='Carbon Black'>CBLK</a>) but raises the price target by a dollar to $24, a 9% downside to yesterday&rsquo;s close.</li><li>               Cowen also <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Carbon+Black+Inc+%28CBLK%29+PT+Raised+to+%2430+at+Cowen%3B+Good+Results+Out+Of+The+Gate/14287407.html\" target=\"_blank\">raises</a> its Carbon Black target a dollar to $30 (14% upside) and maintains an Outperform rating.&nbsp;</li><li>                  Carbon Black shares are&nbsp;<font color='green'>up 0.3%</font>&nbsp;premarket to $26.40.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3362534-carbon-black-plus-1_1-percent-q1-beats-upside-guides\" target=\"_blank\">Carbon Black +1.1% on Q1 beats, upside guides</a> (June 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362692\" data-linked=\"Analyst raise Carbon Black targets after earnings\" data-tweet=\"$CBLK - Analyst raise Carbon Black targets after earnings https://seekingalpha.com/news/3362692-analyst-raise-carbon-black-targets-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3362692-analyst-raise-carbon-black-targets-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362690\" data-ts=\"1528464204\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362690-monster-beverageplus-4-after-annual-meeting-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster Beverage +4% after annual meeting presentation</a></h4><ul> <li>Monster Beverage (NASDAQ:<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corp.'>MNST</a>) is&nbsp;<font color='green'>up 3.77%</font>&nbsp;premarket after management issues a positive outlook at the company's annual meeting yesterday.</li> <li>Analysts are latching on to Monster's assessment that its U.S. business is showing strong momentum and that there is some room to take prices higher later this year to offset elevated input costs on aluminum.</li> <li>Of note, Monster has taken market share from Red Bull over the last year. Susquehanna analyst Pablo Zuanic notes that over the last four-week tracking period Monster's sales were up 7.6% vs. +1.8% for Red Bull.</li> <li><a href=\"https://edge.media-server.com/m6/p/kvvxgspq\" target=\"_blank\">Monster Beverage annual meeting webcast</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3362690\" data-linked=\"Monster Beverage +4% after annual meeting presentation\" data-tweet=\"$MNST - Monster Beverage +4% after annual meeting presentation https://seekingalpha.com/news/3362690-monster-beverageplus-4-after-annual-meeting-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3362690-monster-beverageplus-4-after-annual-meeting-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362687\" data-ts=\"1528463931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDAP\" target=\"_blank\">EDAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362687-premarket-gainers-of-9-05-06-08-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (06/08/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a> <font color='green'>+82%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3362677-edap-tms-76-percent-premarket-fda-ok-focal-one-prostate\" target=\"_blank\">OK</a> of Focal One for prostate.</li>     <li><a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a> <font color='green'>+17%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3362515-zumiez-beats-0_02-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/PAVM' title='PAVmed Inc.'>PAVM</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3362641-pavmed-receive-10_4m-rights-offering-shares-ahead-14-percent-premarket\" target=\"_blank\">receiving</a> $10.4M from rights offering.</li>     <li><a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a> <font color='green'>+7%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3362514-stitch-fix-beats-0_06-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/GALT' title='Galectin Therapeutics, Inc.'>GALT</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3362687\" data-linked=\"Premarket Gainers as of 9:05 am (06/08/2018)\" data-tweet=\"$EDAP $EDAP $ZUMZ - Premarket Gainers as of 9:05 am (06/08/2018) https://seekingalpha.com/news/3362687-premarket-gainers-of-9-05-06-08-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3362687-premarket-gainers-of-9-05-06-08-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362682\" data-ts=\"1528463756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVRS\" target=\"_blank\">CVRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362682-corindus-vascular-up-32-premarket-on-corpath-grx-ok-in-japan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corindus Vascular up 32% premarket on CorPath GRX OK in Japan</a></h4><ul><li>Corindus Vascular Robotics (NYSEMKT:<a href='https://seekingalpha.com/symbol/CVRS' title='Corindus Vascular Robotics, Inc.'>CVRS</a>) is up&nbsp;<font color='green'>32%</font>&nbsp;premarket in response to its <a href=\"https://seekingalpha.com/pr/17187209-corindus-announces-pharmaceutical-medical-device-agency-pmda-approval-corpath-grx-system\" target=\"_blank\">announcement </a>that its CorPath GRX System has been approved in Japan. Efforts to establish reimbursement are underway.</li><li>Japan Medicalnext Co. will distribute.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362682\" data-linked=\"Corindus Vascular up 32% premarket on CorPath GRX OK in Japan\" data-tweet=\"$CVRS - Corindus Vascular up 32% premarket on CorPath GRX OK in Japan https://seekingalpha.com/news/3362682-corindus-vascular-up-32-premarket-on-corpath-grx-ok-in-japan?source=tweet\" data-url=\"https://seekingalpha.com/news/3362682-corindus-vascular-up-32-premarket-on-corpath-grx-ok-in-japan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362678\" data-ts=\"1528463274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362678-premarket-losers-of-9-05-6-8-20180\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (6/8/20180</a></h4><ul> <li><a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>&nbsp;<font color='red'>-55%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3362598-trovagene-announces-pricing-18m-public-offering-shares-58-percent-premarket\" target=\"_blank\">pricing</a> $18M public offering.</li><li><a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3362531-capstone-turbine-beats-0_02-misses-revenue\" target=\"_blank\">FY earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/TOPS' title='TOP Ships Inc.'>TOPS</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3362678\" data-linked=\"Premarket Losers as of 9:05 am (6/8/20180\" data-tweet=\"$TROV $TROV $CPST - Premarket Losers as of 9:05 am (6/8/20180 https://seekingalpha.com/news/3362678-premarket-losers-of-9-05-6-8-20180?source=tweet\" data-url=\"https://seekingalpha.com/news/3362678-premarket-losers-of-9-05-6-8-20180\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362673\" data-ts=\"1528462836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRNA\" target=\"_blank\">DRNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362673-dicerna-down-35-premarket-on-alnylams-lumasiran-data-in-ph1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dicerna down 35% premarket on Alnylam&#39;s lumasiran data in PH1</a></h4><ul><li>Dicerna Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a>) is down&nbsp;<font color='red'>35%</font>&nbsp;premarket, albeit on only 10 shares, on the heels of Alnylam's updated Phase 1/2 data on lumasiran in primary hyperoxaluria type 1 (PH1).</li><li>Dicerna's RNAi candidate for primary hyperoxaluria is Phase 1-stage DCR-PHXC.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3360321-dicerna-advancing-ph-candidate-early-stage-study-shares-4-percent\" target=\"_blank\">Dicerna advancing PH candidate in early-stage study; shares up 4%</a> (May 30)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362623-alnylams-lumasiran-shows-positive-effect-phase-1-2-ph1-study\" target=\"_blank\">Alnylam's lumasiran shows positive effect in Phase 1/2 PH1 study</a> (June 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362673\" data-linked=\"Dicerna down 35% premarket on Alnylam&#39;s lumasiran data in PH1\" data-tweet=\"$DRNA - Dicerna down 35% premarket on Alnylam&#39;s lumasiran data in PH1 https://seekingalpha.com/news/3362673-dicerna-down-35-premarket-on-alnylams-lumasiran-data-in-ph1?source=tweet\" data-url=\"https://seekingalpha.com/news/3362673-dicerna-down-35-premarket-on-alnylams-lumasiran-data-in-ph1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362671\" data-ts=\"1528462732\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXO\" target=\"_blank\">CXO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362671-concho-resourcesminus-6-bernstein-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Concho Resources -6% as Bernstein downgrades</a></h4><ul>     <li>Concho Resources (NYSE:<a href='https://seekingalpha.com/symbol/CXO' title='Concho Resources Inc.'>CXO</a>) <font color='red'>-6%</font> premarket after Bernstein <a href=\"https://thefly.com/thestreet/realmoney/index.php/CXOid2742650/CXO-Concho-downgraded-to-Market-Perform-on-Permian-punishment-at-Bernstein\" target=\"_blank\">downgrades</a> shares to Market Perform from Outperform with a $130 price target, slashed from $180, suggesting investors wait until Q2 results for a potentially better entry point.</li><li>Permian names are being punished, Bernstein analyst Bob Brackett says, due to congestion in the play which means some companies will have attractive routes out and others will not.</li><li><a href=\"https://seekingalpha.com/news/3356035-wsj-overwhelmed-infrastructure-pushes-permian-crude-60-bbl\" target=\"_blank\">Overwhelmed infrastructure</a> is preventing Permian Basin producers from getting their oil to market, threatening profits.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362671\" data-linked=\"Concho Resources -6% as Bernstein downgrades\" data-tweet=\"$CXO - Concho Resources -6% as Bernstein downgrades https://seekingalpha.com/news/3362671-concho-resourcesminus-6-bernstein-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3362671-concho-resourcesminus-6-bernstein-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362664\" data-ts=\"1528461501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMNY\" target=\"_blank\">HMNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362664-helios-and-mathesonplus-11-bullish-sa-article-says-is-unique-opportunity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helios and Matheson +11%, bullish SA article says it is a &#39;unique opportunity&#39;</a></h4><ul><li>Penny stock Helios and Matheson (NASDAQ:<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a>) <font color='green'>+11%</font> premarket on volume of 400K shares.</li><li>A bullish article by Seeking Alpha author Plato Management yesterday notes the MoviePass owner <a href=\"http://mysec.hmna.com/MYSEC/documents/html/hmny20180508_8-K.htm\" target=\"_blank\">recently disclosed</a> that its new \"one movie\" policy have reduced fraud and brought down its utilization rate - which is causing HMNY&nbsp;to burn through cash - by 35%.</li><li>Author says fears HMNY will not make it through the summer are misguided, and says investors can pick up shares for \"pennies on the dollar.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3362664\" data-linked=\"Helios and Matheson +11%, bullish SA article says it is a &#39;unique opportunity&#39;\" data-tweet=\"$HMNY - Helios and Matheson +11%, bullish SA article says it is a &#39;unique opportunity&#39; https://seekingalpha.com/news/3362664-helios-and-mathesonplus-11-bullish-sa-article-says-is-unique-opportunity?source=tweet\" data-url=\"https://seekingalpha.com/news/3362664-helios-and-mathesonplus-11-bullish-sa-article-says-is-unique-opportunity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>89&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362662\" data-ts=\"1528460823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPW\" target=\"_blank\">DPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362662-dpwplus-26-says-paid-down-debt-using-mined-bitcoin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DPW +26%, says it paid down debt using mined bitcoin</a></h4><ul><li>DPW Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a>) <font color='green'>+26%</font> premarket.</li><li>Company says it has used bitcoin, the cryptocurrency its subsidiary Super Crypto Mining has mined through its operations to reduce its debt, \"marking a milestone for the company and possibly the use of Bitcoin on a commercial basis.\"</li><li>SCM actively mines bitcoin.</li><li>DPW incurred new debt recently to support the purchase of Enertec Systems 2001, Israel&rsquo;s largest private developer and manufacturer of specialized electronic systems for the aerospace and defense markets.</li><li><a href=\"https://seekingalpha.com/pr/17187098-dpw-holdings-marks-milestone-reduces-debt-leveraging-bitcoin\" target=\"_blank\">Press release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3362662\" data-linked=\"DPW +26%, says it paid down debt using mined bitcoin\" data-tweet=\"$DPW - DPW +26%, says it paid down debt using mined bitcoin https://seekingalpha.com/news/3362662-dpwplus-26-says-paid-down-debt-using-mined-bitcoin?source=tweet\" data-url=\"https://seekingalpha.com/news/3362662-dpwplus-26-says-paid-down-debt-using-mined-bitcoin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362660\" data-ts=\"1528460646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOCU\" target=\"_blank\">DOCU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362660-analysts-raise-docusign-targets-after-q1-beats-upside-guidance-sharesplus-5_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts raise DocuSign targets after Q1 beats, upside guidance; shares +5.5%</a></h4><ul><li>        Citi <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Docusign+Inc.+%28DOCU%29+PT+Raised+to+%2470+at+Citi/14287634.html\" target=\"_blank\">maintains</a> a Buy rating on DocuSign (NASDAQ:<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a>) and raises the price target from $59 to $70, a 25% upside to yesterday&rsquo;s close.</li><li>               Morgan Stanley <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Docusign+Inc.+%28DOCU%29+PT+Raised+to+%2446+at+Morgan+Stanley/14288043.html\" target=\"_blank\">stays</a> at Equal Weight and bumps the target by $4 to $46.&nbsp;</li><li>               JMP Securities <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Docusign+Inc.+%28DOCU%29+PT+Raised+to+%2463+at+JMP+Securities/14287413.html\" target=\"_blank\">raises</a> its target from $52 to $63 and maintains a Market Outperform rating. &nbsp;&nbsp;</li><li>               DocuSign shares are<font color='green'>&nbsp;up 5.5%&nbsp;</font>premarket to $59.06.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362525-docusign-plus-10_7-percent-first-earnings-ipo-beats-estimates-upside-guide\" target=\"_blank\">DocuSign +10.7% on first earnings after IPO beats estimates with upside guide</a> (June 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362660\" data-linked=\"Analysts raise DocuSign targets after Q1 beats, upside guidance; shares +5.5%\" data-tweet=\"$DOCU - Analysts raise DocuSign targets after Q1 beats, upside guidance; shares +5.5% https://seekingalpha.com/news/3362660-analysts-raise-docusign-targets-after-q1-beats-upside-guidance-sharesplus-5_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3362660-analysts-raise-docusign-targets-after-q1-beats-upside-guidance-sharesplus-5_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362658\" data-ts=\"1528460586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDAP\" target=\"_blank\">EDAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362658-edapplus-75-on-fda-approval-of-focal-one\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EDAP +75% on FDA approval of Focal One</a></h4><ul><li>EDAP&nbsp;(NASDAQ:<a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a>)&nbsp;<font color='green'>+75%</font> pre-market.</li><li>Late yesterday EDAP announced it had received 510(k) clearance from the FDA for its Focal One device for the ablation of prostate tissue.</li><li>Focal One high is the first medical device designed specifically for focal treatment of the prostate.</li><li>With Focal One, urology surgeons can establish precise contours around diseased tissue and ablate a smaller portion of the prostate.</li><li><a href=\"https://seekingalpha.com/pr/17186895-edap-tms-sa-edap-announces-fda-clearance-focal-one\" target=\"_blank\">Press release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3362658\" data-linked=\"EDAP +75% on FDA approval of Focal One\" data-tweet=\"$EDAP - EDAP +75% on FDA approval of Focal One https://seekingalpha.com/news/3362658-edapplus-75-on-fda-approval-of-focal-one?source=tweet\" data-url=\"https://seekingalpha.com/news/3362658-edapplus-75-on-fda-approval-of-focal-one\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362656\" data-ts=\"1528460562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIVN\" target=\"_blank\">LIVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362656-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>LIvaNova (NASDAQ:<a href='https://seekingalpha.com/symbol/LIVN' title='LivaNova PLC'>LIVN</a>) initiated with Buy rating and $115 (20% upside) price target at Stifel.</li><li>Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) initiated with Overweight rating and $100 (16% upside) price target at Cantor Fitzgerald.</li><li>Pfizer (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) initiated with Overweight rating and $45 (23% upside) price target at Cantor.</li><li>LeMaitre Vascular (NASDAQ:<a href='https://seekingalpha.com/symbol/LMAT' title='LeMaitre Vascular, Inc.'>LMAT</a>) resumed with Buy rating and $38 (13% upside) price target at Roth Capital.</li><li>Quest Diagnostics (NYSE:<a href='https://seekingalpha.com/symbol/DGX' title='Quest Diagnostics Incorporated'>DGX</a>) upgraded to Outperform with a $115 (7% upside) price target at William Blair.</li><li>DexCom (NASDAQ:<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a>) upgraded to Overweight with a $115 (29% upside) price target at JPMorgan. Shares up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3362656\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$LIVN $LIVN $LLY - Premarket analyst action - healthcare https://seekingalpha.com/news/3362656-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3362656-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362654\" data-ts=\"1528460227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZUMZ\" target=\"_blank\">ZUMZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362654-zumiezplus-16-on-sales-improvment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zumiez +16% on sales improvment</a></h4><ul> <li>Zumiez (NASDAQ:<a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a>) is up sharply after posting 8% comparable store sales growth in Q1.</li> <li>The retailer also tipped off that it plans to open around 13 new stores in FY18, including six in the U.S., five in Europe, and two in Australia. About half of the openings are expected in time for the back-to-school season, according to execs.</li> <li><a href=\"https://seekingalpha.com/article/4180237-zumiez-inc-zumz-ceo-richard-brooks-q1-2018-results-earnings-call-transcript\" target=\"_blank\">Zumiez earnings call transcript</a></li> <li>Shares of Zumiez are <font color='green'>up 15.56%</font> in premarket trading to $31.20, well-above the 52-week high of $27.00.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362515-zumiez-beats-0_02-beats-revenue\" target=\"_blank\">Zumiez beats by $0.02, beats on revenue</a> (June 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362522-zumiez-beats-comparable-store-sales-estimates\" target=\"_blank\">Zumiez beats comparable store sales estimates</a> (June 7)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3362654\" data-linked=\"Zumiez +16% on sales improvment\" data-tweet=\"$ZUMZ - Zumiez +16% on sales improvment https://seekingalpha.com/news/3362654-zumiezplus-16-on-sales-improvment?source=tweet\" data-url=\"https://seekingalpha.com/news/3362654-zumiezplus-16-on-sales-improvment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362641\" data-ts=\"1528459512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAVM\" target=\"_blank\">PAVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362641-pavmed-to-receive-10_4m-from-rights-offering-shares-ahead-14-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PAVmed to receive $10.4M from rights offering; shares ahead 14% premarket</a></h4><ul> <li>PAVmed's (NASDAQ:<a href='https://seekingalpha.com/symbol/PAVM' title='PAVmed Inc.'>PAVM</a>) previously announced equity rights offering <a href=\"https://seekingalpha.com/pr/17187090-pavmed-receive-10_4-million-gross-proceeds-oversubscribed-rights-offering\" target=\"_blank\">expired</a> on June 7 and, as such, the rights are no longer exercisable. The subscriptions exceeded the number of rights       available and the Company has accepted all       valid subscriptions including up to 9M units of the total       oversubscribed amount.</li><li>PAVmed expects the Rights Offering will result in gross       proceeds of ~$10.4M.</li><li>Closing date is June 12.</li>          <li>Each right entitled the holder to purchase one unit at a price of $1.15 per unit, consisting of one common share and one Series Z Warrant to       purchase one share of common stock with an exercise price of $1.60.</li><li>Shares are up&nbsp;<font color='green'>14%</font>&nbsp;premarket.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3362641\" data-linked=\"PAVmed to receive $10.4M from rights offering; shares ahead 14% premarket\" data-tweet=\"$PAVM - PAVmed to receive $10.4M from rights offering; shares ahead 14% premarket https://seekingalpha.com/news/3362641-pavmed-to-receive-10_4m-from-rights-offering-shares-ahead-14-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3362641-pavmed-to-receive-10_4m-from-rights-offering-shares-ahead-14-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362644\" data-ts=\"1528459385\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPZ\" target=\"_blank\">DPZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362644-maxim-to-sidelines-on-dominos-after-big-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxim to the sidelines on Domino&#39;s after big rally</a></h4><ul> <li>Maxim Group lowers Domino's Pizza (NYSE:<a href='https://seekingalpha.com/symbol/DPZ' title='Domino&#39;s Pizza, Inc.'>DPZ</a>) to a <a href=\"https://www.streetinsider.com/Downgrades/UPDATE%3A+Maxim+Downgrades+Dominos+Pizza+%28DPZ%29+to+Hold/14287984.html\" target=\"_blank\">Hold rating</a> on a valuation call after having the pizza chain set at Buy.</li> <li>The investment firm observes that Domino's ran right up to its price target of $270 with its blistering 43% YTD rally.</li> <li>DPZ <font color='red'>-1.11%</font> premarket to $269.01</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3362644\" data-linked=\"Maxim to the sidelines on Domino&#39;s after big rally\" data-tweet=\"$DPZ - Maxim to the sidelines on Domino&#39;s after big rally https://seekingalpha.com/news/3362644-maxim-to-sidelines-on-dominos-after-big-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3362644-maxim-to-sidelines-on-dominos-after-big-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362639\" data-ts=\"1528458944\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362639-nar-apple-drops-iphone-parts-orders-20-supplier-stocks-dip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NAR: Apple drops iPhone parts orders by 20%; supplier stocks dip</a></h4><ul><li>Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) has warned suppliers of a 20% drop in new orders for iPhone parts, according to <a href=\"https://asia.nikkei.com/Business/Companies/Apple-warns-suppliers-of-20-drop-in-new-iPhone-parts-orders\" target=\"_blank\">Nikkei Asian Review sources</a>.</li><li>NAR&rsquo;s source: \"Apple is quite conservative in terms of placing new orders for upcoming iPhones this year. For the three new models specifically, the total planned capacity could be up to 20% fewer than last year's orders.\"</li><li>Last year, Apple placed orders to prepare 100M production units of the iPhone 8 models and the iPhone X. Sources say Apple expects 80M total shipments of the new iPhones.</li><li>Total iPhone shipments dropped 1% Y/Y in the December quarter to 77.31M. Global smartphone shipments declined 0.3% to 1.46B units last year for the first-ever industry decline, according to IDC data.</li><li>Apple suppliers that could move on the news:&nbsp;                  Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>), Cirrus Logic (NASDAQ:<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a>), Finisar (NASDAQ:<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>), II-VI (NASDAQ:<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a>), Lumentum (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>), Qorvo (NASDAQ:<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a>), Skyworks Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a>), STMicroelectronics (NYSE:<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a>), Universal Display (NASDAQ:<a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a>).&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362628-tsmc-minus-2_6-percent-soft-may-revenue\" target=\"_blank\">TSMC -2.6% on soft May revenue</a> (June 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362639\" data-linked=\"NAR: Apple drops iPhone parts orders by 20%; supplier stocks dip\" data-tweet=\"$AAPL $AAPL $AVGO - NAR: Apple drops iPhone parts orders by 20%; supplier stocks dip https://seekingalpha.com/news/3362639-nar-apple-drops-iphone-parts-orders-20-supplier-stocks-dip?source=tweet\" data-url=\"https://seekingalpha.com/news/3362639-nar-apple-drops-iphone-parts-orders-20-supplier-stocks-dip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>146&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362628\" data-ts=\"1528457536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362628-tsmcminus-2_6-on-soft-may-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TSMC -2.6% on soft May revenue</a></h4><ul><li>        Taiwan Semiconductor Manufacturing Co. (NYSE:<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a>) <a href=\"https://www.digitimes.com/news/a20180608VL204.html\" target=\"_blank\">reports</a> $2.72B in revenue from May 2018, down 1.1% on the month but up 11.2% Y/Y.</li><li>               TSMC expects revenue of $7.8B to $7.9B in Q2, down 7% to 8% Q/Q.&nbsp;</li><li>               TSMC&rsquo;s cumulative 2018 revenue through May totaled $13.7B, up 13% Y/Y.&nbsp;</li><li>               The company cut its 2018 forecast to a 10% growth from 10% to 15% at the most recent investors meeting due to weaker smartphone demand and growing cryptocurrency uncertainty.&nbsp;</li><li>               In other TSMC news, the company is <a href=\"https://www.digitimes.com/news/a20180608PD211.html\" target=\"_blank\">accelerating mass production</a> of its 7nm process technology to meet increasing demand and says major fabless clients like Qualcomm plan to skip 10nm to go directly to 7nm.&nbsp;</li><li>               Volume production now moves to Q2 and the foundry expects sales from the node to account for over 20% of revenue in Q4 and 10% for the year.&nbsp;</li><li>               Taiwan Semi shares are&nbsp;<font color='red'>down 2.6%</font>&nbsp;premarket to $38.50.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3358900-bloomberg-tsmc-mass-producing-7nm-chips-apples-iphones\" target=\"_blank\">Bloomberg: TSMC mass producing 7nm chips for Apple's iPhones</a> (May 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3355172-tsmc-reports-44-percent-y-y-revenue-growth-april\" target=\"_blank\">TSMC reports 44% Y/Y revenue growth for April</a> (May 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362628\" data-linked=\"TSMC -2.6% on soft May revenue\" data-tweet=\"$TSM - TSMC -2.6% on soft May revenue https://seekingalpha.com/news/3362628-tsmcminus-2_6-on-soft-may-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3362628-tsmcminus-2_6-on-soft-may-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362598\" data-ts=\"1528453450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362598-trovagene-announces-pricing-of-18m-public-offering-shares-down-58-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trovagene announces pricing of $18M public offering; shares down 58% premarket</a></h4><ul> <li>Trovagene (NASDAQ:<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>) <a href=\"https://seekingalpha.com/pr/17186969-trovagene-inc-announces-pricing-18-million-public-offering\" target=\"_blank\">prices</a> its public offering of 18M shares of common stock and common stock warrants to purchase 18M shares of common stock at a price of $1.00 per share and accompanying warrant.&nbsp;The warrants will have an exercise price of&nbsp;$1.10, and will expire 5 years from the date of issuance.</li><li>Underwriters over-allotment is an&nbsp;additional 2.7M shares and/or warrants.</li>   <li>The estimated net proceeds of ~$16.2M will be used to fund its R&amp;D activities and for working capital and general corporate purposes.</li><li>Closing date is June 12.</li><li>Shares are down&nbsp;<font color='red'>58%</font>&nbsp;premarket.</li><li><strong>Update</strong>: On June 12, it <a href=\"https://seekingalpha.com/pr/17190129-trovagene-inc-announces-closing-18-million-public-offering\" target=\"_blank\">announced </a>that it raised gross proceeds of $18M. Underwriters exercised their option to purchase warrants to buy up to 2.7M common shares.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3362598\" data-linked=\"Trovagene announces pricing of $18M public offering; shares down 58% premarket\" data-tweet=\"$TROV - Trovagene announces pricing of $18M public offering; shares down 58% premarket https://seekingalpha.com/news/3362598-trovagene-announces-pricing-of-18m-public-offering-shares-down-58-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3362598-trovagene-announces-pricing-of-18m-public-offering-shares-down-58-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3362590\" data-ts=\"1528451186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOS\" target=\"_blank\">SHOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3362590-on-sears-hometown-and-outlet-stores-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Sears Hometown and Outlet Stores&#39; Q1</a></h4><ul><li>Sears Hometown and Outlet (NASDAQ:<a href='https://seekingalpha.com/symbol/SHOS' title='Sears Hometown and Outlet Stores, Inc.'>SHOS</a>) reports comparable-store sales fell 10.5% in <a href=\"https://seekingalpha.com/pr/17187009-sears-hometown-outlet-stores-inc-reports-first-quarter-2018-results\" target=\"_blank\">Q1</a>.</li><li>Comp for Hometown and Outlet decreased 11.6% and 8.3%.</li><li>Segment sales: Hometown:$253.7M (-14.6%); Outlet sales: $127.8M (-15.5%).</li><li>Gross margin rate improved 200 bps to 22.9%.</li><li>SG&amp;A expense rate down 100 bps to 23.7%.</li><li>Merchandise inventories down 10.7% to $332.45M.</li><li>Store count -130 Y/Y to 882.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362589-sears-hometown-outlet-reports-q1-results\" target=\"_blank\">Sears Hometown and Outlet reports Q1 results</a> (June 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3362590\" data-linked=\"More on Sears Hometown and Outlet Stores&#39; Q1\" data-tweet=\"$SHOS - More on Sears Hometown and Outlet Stores&#39; Q1 https://seekingalpha.com/news/3362590-on-sears-hometown-and-outlet-stores-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3362590-on-sears-hometown-and-outlet-stores-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":63,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}